Compare WAVE & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | WAVE | ELOX |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Israel | United States |
| Employees | N/A | 7 |
| Industry | Electric Utilities: Central | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 41.0M |
| IPO Year | 2021 | N/A |
| Metric | WAVE | ELOX |
|---|---|---|
| Price | $7.86 | $11.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 60.6K | 51.3K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $436.84 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.52 | $10.00 |
| 52 Week High | $10.87 | $15.00 |
| Indicator | WAVE | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 39.21 | 42.12 |
| Support Level | $6.73 | $10.51 |
| Resistance Level | $8.49 | $14.43 |
| Average True Range (ATR) | 0.48 | 1.76 |
| MACD | -0.15 | 0.07 |
| Stochastic Oscillator | 3.12 | 29.03 |
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.